MRC1 and neoplasm: In the Lewis lung cancer (LLC) animal model, Hughes et al. discovered that chemotherapeutic drug treatment caused tumor cells to release CXCL12, which improved CD206+ TAM invasion, prevented tumor cell death, and aided tumor recurrence (78).